Related content

Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody

By Carter Teresa   Sterling-Levis Katy   Ow Kim   Doughty Larissa   Hattarki Meghan   Shapira Deborah   Hewish Dean   Kortt Alexander   Russell Pamela  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 533-542

Springer Publishing Company

Access to resources Recommend Favorite

Radioimmunotherapy of DU-145 Tumours in Nude Mice: A Pilot Study with E4, A Novel Monoclonal Antibody Against Prostate Cancer

By Rydh Anders   Riklund-Åhlström Katrine   Widmark Anders   Bergh Anders   Johansson Lennart   Tavelin Björn   Nilsson Sten   Stigbrand Torgny   Damber Jan-Erik   Hietala Sven-Ola  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1075-1079

Informa Healthcare

Access to resources Recommend Favorite

Development of a 124I-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution

By          

International Journal of Oncology, Vol. 44, Iss. 6, 2014-01 ,pp. : 1998-2008

Spandidos Publications

Access to resources Recommend Favorite

Dynamic MRI and CAD vs. Choline MRS: Where is the detection level for a lesion characterisation in prostate cancer?

By Schmuecking Michael   Boltze Carsten   Geyer Hagen   Salz Henning   Schilling Bert   Wendt Thomas   Kloetzer Karl-Heinz   Marx Christiane  

International Journal of Radiation Biology, Vol. 85, Iss. 9, 2009-09 ,pp. : 814-824

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite